Actuate Therapeutics Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Dan Schmitt
Chief executive officer
US$520.0k
Total compensation
CEO salary percentage | 76.9% |
CEO tenure | 9.3yrs |
CEO ownership | 2.9% |
Management average tenure | no data |
Board average tenure | 1.8yrs |
Recent management updates
No updates
Recent updates
No updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Mar 31 2024 | n/a | n/a | -US$28m |
Dec 31 2023 | US$520k | US$400k | -US$25m |
Compensation vs Market: Dan's total compensation ($USD520.00K) is below average for companies of similar size in the US market ($USD1.46M).
Compensation vs Earnings: Insufficient data to compare Dan's compensation with company performance.
CEO
Dan Schmitt (62 yo)
9.3yrs
Tenure
US$520,000
Compensation
Mr. Daniel M. Schmitt, also known as Dan, serves as Chief Executive Officer and President at Actuate Therapeutics, Inc. since March 2015. Mr. Schmitt served as Chief Operating Officer of Genus Oncology, LL...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, President & Director | 9.3yrs | US$520.00k | 2.93% $ 5.1m | |
Independent Director | 1.8yrs | no data | no data | |
Member of Scientific Advisory Board | 1.8yrs | no data | no data | |
Member of Scientific Advisory Board | 1.8yrs | no data | no data | |
Member of Scientific Advisory Board | 1.8yrs | no data | no data | |
Independent Director | 3.3yrs | no data | 0.40% $ 693.4k | |
Independent Director | 9.3yrs | no data | 0.37% $ 630.0k | |
Independent Chairman | 9.3yrs | no data | 0.41% $ 700.0k | |
Member of Scientific Advisory Board | 1.8yrs | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data |
1.8yrs
Average Tenure
62yo
Average Age
Experienced Board: ACTU's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.